Ali Behbahani, M.D.

Ali Behbahani, M.D.

DirectoratMonte Rosa Therapeutics· In the 2024 proxy

Ali Behbahani, M.D. sits on 8 public boards.

Experience

  1. Monte Rosa TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +93%
  2. Black Diamond Therapeutics, Inc.Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  3. Nkarta, Inc.Public company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  4. Adaptimmune TherapeuticsPublic company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  5. CVRx, Inc.Public company · 11 yr
    • Director2013 – 2024 · 11 yrNo stock prices for these years
  6. Minerva Surgical Inc.Public company · 13 yr
    • Director2011 – 2024 · 13 yrNo stock prices for these years
  7. Oyster Point Pharma, Inc.Public company · 6 yr
    • Director2017 – 2023 · 6 yrNo stock prices for these years
  8. Genocea Biosciences, Inc.Public company · 4 yr
    • Director2018 – 2022 · 4 yrNo stock prices for these years
  9. Nevro Corp.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?